Murthi G V, Kocyildirim E, Sellathury S, Cuckow P M, Wilcox D T, Michalski A, Sebire N J, Elliott M J, Duffy P G
Department of Paediatric Urology, Great Ormond Street Hospital for Children, London, WC1N 3JH, UK.
J Pediatr Urol. 2006 Oct;2(5):439-45. doi: 10.1016/j.jpurol.2005.10.004. Epub 2005 Dec 1.
To review the surgical management of Wilms' tumour with persistent intravascular (vena caval +/- atrial) tumour extension.
Data were collected regarding operative details, tumour and 'thrombus' histology, and long-term outcome for patients with Wilms' tumour with cavo-artial extension.
From 1988 to 2004, 13 patients underwent treatment for Wilms' tumour with persistent intravascular extension. Preoperative chemotherapy was administered in 11/13 patients and postoperative radiotherapy in eight patients. Intravascular involvement was upto IVC (5), and right atrium (8) patients. Techniques employed for excision of intra-vascular component were: local cavotomy (3), extensive infra-diaphragmatic cavotomy without cardiopulmonary bypass (CPB) (1), and excision of cavo-atrial tumour with CPB (+/- hypothermia and cardiac arrest) (9). Mean time on CPB was 90 min. Caval repair was accomplished by primary repair (6) and pericardial graft in (7) patients. There were no intraoperative deaths and few major complications. Tumour thrombus contained malignant cells in 10/13 cases. Mean follow up has been for 55.4 months. To date, seven patients remain disease-free (one lost to follow up), disease recurred in five patients, three of whom have died. There were no symptoms related to the graft.
Surgery for Wilms' tumour with persistent intravascular extension despite chemotherapy is technically challenging. CPB +/- hypothermia and cardiac arrest and extensive caval repair with a graft is safe and reliable in the long term.
回顾伴有持续性血管内(腔静脉±心房)肿瘤扩展的肾母细胞瘤的外科治疗。
收集了伴有腔静脉-心房扩展的肾母细胞瘤患者的手术细节、肿瘤及“血栓”组织学资料以及长期预后情况。
1988年至2004年,13例伴有持续性血管内扩展的肾母细胞瘤患者接受了治疗。11/13例患者接受了术前化疗,8例患者接受了术后放疗。血管内受累情况为:腔静脉受累5例,右心房受累8例。用于切除血管内成分的技术有:局部腔静脉切开术(3例)、不进行体外循环(CPB)的广泛膈下腔静脉切开术(1例)以及在CPB(±低温和心脏停搏)下切除腔静脉-心房肿瘤(9例)。CPB平均时间为90分钟。腔静脉修复通过一期修复(6例)和心包补片修复(7例)完成。术中无死亡病例,主要并发症较少。13例中有10例肿瘤血栓含有恶性细胞。平均随访时间为55.4个月。迄今为止,7例患者无疾病复发(1例失访),5例患者疾病复发,其中3例死亡。未出现与补片相关的症状。
尽管进行了化疗,但伴有持续性血管内扩展的肾母细胞瘤的手术在技术上具有挑战性。长期来看,CPB±低温和心脏停搏以及使用补片进行广泛的腔静脉修复是安全可靠的。